Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Bio-Gene Technology Limited ABN/ARBN Financial year ended: 32 071 735 950 30 June...
Appendix 4G
Filed with ASX · · 13 pages · English
On 6ix: 6ix.com/news/appendix-4g-60
Release
Bio-Gene Technology Ltd. on 6ix
Earlier from Bio-Gene Technology
- Change in substantial holding
- Notification regarding unquoted securities - BGT
- Change of Director's Interest Notice x 4
- Placement Completed and Cleansing Notice
- Application for quotation of securities - BGT
Later from Bio-Gene Technology
- Corporate Governance Statement
- Appendix 4E and 2026 Annual Report
- Flavocide efficacy results against deer ticks published
- Date of 2026 Annual General Meeting
- Bio-Gene Receives $343,000 R&D Tax Incentive
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology